Gene · 10188
Papers1,711
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,711
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Repeated intravenous thrombolysis for ischaemic stroke with medium to large vessel occlusion presenting within 4.5 hours of onset with tenecteplase in China (RITIS-TNK2): protocol for a prospective, randomised, open-label, blinded assessment of outcome and multicentre study. | BMJ Open | 2026 | 42629154 | PubTator, text mining | PubMed |
| Potential small-molecule tyrosine kinase inhibitors (TKIs) for the treatment of triple-negative breast cancer (TNBC): Targets, structure-activity relationships, and clinical studies. | Eur J Med Chem | 2026 | 42612290 | PubTator, text mining | PubMed |
| Beyond acetylation: Evaluating the emerging biology of lysine acylation. | Cell Chem Biol | 2026 | 42586062 | PubTator, text mining | PubMed |
| Process-resolved effects of dibutyl phthalate on sludge anaerobic fermentation: Enzyme inhibition and metabolic disruption underlie the suppression of acidogenesis. | J Hazard Mater | 2026 | 42585962 | PubTator, text mining | PubMed |
| ACK family tyrosine kinases as potential therapeutic targets for cancer. | Expert Opin Ther Targets | 2026 | 42504143 | PubTator, text mining | PubMed |
| A Novel BRAF-TNK2 Fusion in a Teenage Girl With Pilocytic Astrocytoma. | Pediatr Blood Cancer | 2026 | 42500922 | PubTator, text mining | PubMed |
Genetic heterogeneity, movement disorders, and white matter abnormalities in pediatric developmental and epileptic encephalopathies: A retrospective cohort study from a National Neurodegenerative and Leukodystrophy Registry. | Epilepsy Res | 2026 | 42407302 | PubTator, text mining | PubMed |
| Quinoline-2-carboxamide-phenylacetamide hybrids as preliminary antimicrobial and cytotoxic hits: Synthesis, biological screening, molecular docking, and in silico ADMET profiling. | J Comput Aided Mol Des | 2026 | 42249128 | PubTator, text mining | PubMed |
| Screening of molecular signatures from microRNA and mRNA expression profiling related to the efficacy of the antidepressant duloxetine and analysis of their regulatory relationship. | Biomed Pharmacother | 2026 | 41997083 | PubTator, text mining | PubMed |
| Development and Launch of a Dutch Mobile App (MediMama) on Over-the-Counter Medication Safety During Pregnancy and Breastfeeding: Development and Usability Study. | JMIR Mhealth Uhealth | 2026 | 41926731 | PubTator, text mining | PubMed |
| Synthesis and Biological Activity Characterization of Vascular Endothelial Growth Factor Using an Optimized Wheat Germ Cell-Free System. | Curr Issues Mol Biol | 2026 | 41899442 | PubTator, text mining | PubMed |
| The JMJD family histone demethylases: structure, mechanism of action, diseases and therapeutic targets. | Mol Biomed | 2026 | 41857315 | PubTator, text mining | PubMed |
| An integrative framework for drug target discovery bridging clinical trial and genetic data insights. | J Transl Med | 2026 | 41827014 | PubTator, text mining | PubMed |
| TopoSleuth, a decoy-based multi-layered defense framework for securing SDN topology discovery. | Sci Rep | 2026 | 41820499 | PubTator, text mining | PubMed |
| Stratified signaling network remodeling of kinase-transcription factors' interactions in Parkinson's disease. | Bioinform Adv | 2026 | 41782681 | PubTator, text mining | PubMed |
| There may be a differential mechanistic impact on colorectal cancer of lactose-containing foods between lactase persistent and lactase non-persistent populations. | Front Nutr | 2026 | 41756623 | PubTator, text mining | PubMed |
| Advances in the Understanding of Akt Signaling in Cancers and the Potential of Inhibiting Akt-Driven Tumors Using Small Molecule Inhibitors: An Overview. | Cancers (Basel) | 2026 | 41749835 | PubTator, text mining | PubMed |
| Non-hydrolyzable acetyllysine analogs to study protein acetylation in vitro and in cells. | Nat Commun | 2026 | 41723125 | PubTator, text mining | PubMed |
| Smartphone-Based Contingency Management for Patients Who Use Methamphetamine: Qualitative Analysis of Patient and Clinician Perspectives. | JMIR Form Res | 2026 | 41711389 | PubTator, text mining | PubMed |
| Ensemble machine learning for proactive android ransomware detection using network traffic. | Sci Rep | 2026 | 41708682 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10188/papers